CureBiotech is a company that provides intratumoral immunotherapy solutions for metastatic melanoma. It develops two hydrogel-based injectable formulations for resiquimod, an immune response modifier. The company also offers a combination of CB101 and radiation therapy in head and neck squamous cell carcinoma.